IRA side effect: Pharma companies will increasingly skip Medicare altogether, Lilly CEO says
- Leo Zini
- Jun 14, 2023
- 1 min read
As the Centers for Medicare and Medicaid Services races to finalize guidance on how it will negotiate — or dictate, depending on if you ask a pharma exec — the prices of the costliest medicines in the US, pharma execs are warning of unwanted repercussions...